Effect of thrombin inhalation in a murine model of bronchial asthma

T. Takagi, M. Onishi, M. Naito, A. Fujiwara, T. Kobayashi, H. Kobayashi, C. D‘Alessandro-Gabazza, E. Gabazza, O. Taguchi (Tsu, Japan)

Source: Annual Congress 2011 - Experimental modulation of airway inflammation
Session: Experimental modulation of airway inflammation
Session type: Thematic Poster Session
Number: 4104
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Takagi, M. Onishi, M. Naito, A. Fujiwara, T. Kobayashi, H. Kobayashi, C. D‘Alessandro-Gabazza, E. Gabazza, O. Taguchi (Tsu, Japan). Effect of thrombin inhalation in a murine model of bronchial asthma. Eur Respir J 2011; 38: Suppl. 55, 4104

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of a thrombin inhibitor on murine bronchial asthma
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009

Effect of oral procaterol on allergic inflammation examined by a murine asthmatic model
Source: Eur Respir J 2003; 22: Suppl. 45, 286s
Year: 2003

Effect of neutrophil elastase inhibitor on airway inflammation and airway hyperresponsiveness in a murine model of asthma
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009


Effect of decrease allergen exposition in preventing the bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 504s
Year: 2005

Effect of 1,25(OH)2D3 on the airway inflammation in asthmatic rat model
Source: Eur Respir J 2005; 26: Suppl. 49, 580s
Year: 2005

Influence of endogenous corticosteroids on bronchial protective properties of β2-agonist in patients with bronchial asthma with cold bronchial hyperresponsiveness
Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators
Year: 2010

Experimental specific immunotherapy with timpol decreases allergic sensitization and airway inflammation in murine model of bronchial asthma
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010


Influence of decreased allergen exposition in preventing bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 118s
Year: 2002

Effects of IL-4Rα blockade on lung inflammation and airway hyperresponsiveness using Mu317RAXMu, a murine surrogate for AMG 317, in a treatment model of cockroach allergen-induced asthma in mice
Source: Annual Congress 2008 - Novel mechanisms in the pathogenesis of pulmonary inflammation
Year: 2008

Influence of airway epithelial cell thickness on hyperreactivity of airways of a murine asthma model
Source: Eur Respir J 2007; 30: Suppl. 51, 362s
Year: 2007

Protective effect of thrombomodulin in a murine model of allergen-induced asthma
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010

Dose dependent effect of thrombomodulin in a murine model of allergen-induced asthma
Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation
Year: 2012

Pharmacological characterization of the protective effect of mepolizumab against airway hyperresponsiveness in a human ex vivo model of severe asthma
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019

Repeated inhaled airway allergen challenge model in asthma
Source: Annual Congress 2009 - Inflammation and airways
Year: 2009

Induction of arginase by exposure to air pollution exacerbates the airways symptoms in murine models of asthma
Source: Annual Congress 2010 - Causal factors and mechanisms of outdoor air pollution and nanoparticulates
Year: 2010


Effect of roflumilast on neutrophilic asthma model
Source: International Congress 2017 – Animal models of asthma and allergies
Year: 2017

Uridine is protective in a murine model of bronchial asthma
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009

The PAR2-activating peptide SLIGRL inhibits airway hyper-responsiveness and eosinophilia in an acute murine model of allergic asthma
Source: Annual Congress 2004 - Animal models of asthma and chronic bronchitis and their relevance in pulmonary pharmacology
Year: 2004


Pharmacological characterization of the protective effect of benralizumab against airway hyperresponsiveness in a human ex vivo model of severe asthma
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019

Deficiency of tenascin C attenuates airway hyperresponsiveness in an experimental model of bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 585s
Year: 2005